IceCure Medical (ICCM) vs enVVeno Medical (NVNO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
enVVeno Medical is the larger company by market cap ($5.7 million vs $5.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ICCM | NVNO |
|---|---|---|
| Share price | $1.13 | $8.18 |
| Market cap | $5.24M | $5.68M |
| 1-day change | -1.74% | -2.68% |
| EPS (TTM) | $-6.84 | $-24.99 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $30.30 | $30.80 |
| 52-week low | $1.05 | $7.01 |
| Distance from 52-week high | -96.27% | -73.46% |
| Analyst consensus | none | none |
| Avg. price target upside | +1906.19% | +266.97% |
| Average volume | 136.91K | 23.71K |
| Shares outstanding | 4.64M | 694.83K |
| Employees | 67 | 33 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About IceCure Medical
ICCM stock →IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.
Healthcare · Medical Devices · 67 employees
About enVVeno Medical
NVNO stock →enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency.
Healthcare · Medical Devices · 33 employees
ICCM vs NVNO FAQ
Which is bigger, IceCure Medical or enVVeno Medical?
enVVeno Medical (NVNO) is larger, with a market capitalization of $5.68M compared with $5.24M for IceCure Medical (ICCM).
Are IceCure Medical and enVVeno Medical in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.